Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy
Article first published online: 10 AUG 2007
Copyright © 2007 Wiley Periodicals, Inc.
Medicinal Research Reviews
Volume 28, Issue 3, pages 372–412, May 2008
How to Cite
Li, R. and Morris, S. W. (2008), Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy. Med. Res. Rev., 28: 372–412. doi: 10.1002/med.20109
- Issue published online: 26 MAR 2008
- Article first published online: 10 AUG 2007
- NIH grants. Grant Number: R01 CA69129
- Cancer Center CORE. Grant Number: CA21765
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.
Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.